WallStreetZenWallStreetZen

NASDAQ: ANIK
Anika Therapeutics Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

ANIK past revenue growth

How has ANIK's revenue growth performed historically?
Company
6.67%
Industry
9.45%
Market
17.7%
ANIK's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ANIK's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
ANIK's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

ANIK earnings and revenue history

Current Revenue
$166.7M
Current Earnings
-$82.7M
Current Profit Margin
-49.6%

ANIK Return on Equity

Current Company
-32%
Current Industry
10.5%
Current Market
188%
ANIK's Return on Equity (-32%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when ANIK announces earnings.

ANIK Return on Assets

Current Company
-26.1%
Current Industry
5.3%
ANIK is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ANIK Return on Capital Employed

Current Company
-36.58%
Current Industry
8.3%
ANIK's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ANIK vs Medical Device Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ANIK$166.66M-$71.19M-$82.67M+9.56%N/A
NVRO$425.17M-$78.31M-$92.21M+1.88%N/A
MXCT$41.29M-$33.36M-$37.92M+17.55%N/A
NPCE$65.42M-$22.83M-$32.96M+15.33%N/A
SRDX$138.20M$22.74M$5.52M+9.81%-5.06%
View Top Medical Device Stocks

ANIK earnings dates

Next earnings date
Jun 13, 2024

Anika Therapeutics Earnings & Revenue FAQ

What were ANIK's earnings last quarter?

On Invalid Date, Anika Therapeutics (NASDAQ: ANIK) reported Q4 2023 earnings per share (EPS) of -$4.30, up 1,164.71% year over year. Total Anika Therapeutics earnings for the quarter were -$63.00 million. In the same quarter last year, Anika Therapeutics's earnings per share (EPS) was -$0.34.

If you're new to stock investing, here's how to buy Anika Therapeutics stock.

What was ANIK's earnings growth in the past year?

As of Q2 2024, Anika Therapeutics's earnings has grown year over year. Anika Therapeutics's earnings in the past year totalled -$82.67 million.

What is ANIK's earnings date?

Anika Therapeutics's earnings date is Invalid Date. Add ANIK to your watchlist to be reminded of ANIK's next earnings announcement.

What was ANIK's revenue last quarter?

On Invalid Date, Anika Therapeutics (NASDAQ: ANIK) reported Q4 2023 revenue of $42.97 million up 8.45% year over year. In the same quarter last year, Anika Therapeutics's revenue was $39.62 million.

What was ANIK's revenue growth in the past year?

As of Q2 2024, Anika Therapeutics's revenue has grown 6.67% year over year. This is 2.78 percentage points lower than the US Medical Devices industry revenue growth rate of 9.45%. Anika Therapeutics's revenue in the past year totalled $166.66 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.